Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

Conditions

Coronavirus

Keywords

Immunity

Brief summary

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Jia X, Cao S, Lee AS, Manohar M, Sindher SB, Ahuja N, Artandi M, Blish CA, Blomkalns AL, Chang I, Collins WJ, Desai M, Din HN, Do E, Fernandes A, Geng LN, Rosenberg-Hasson Y, Mahoney MR, Glascock AL, Chan LY, Fong SY, CLIAHUB Consortium, Chan Zuckerberg Biohub, Phelps M, Raeber O, Stanford COVID-19 Biobank Study Group, Purington N, Röltgen K, Rogers AJ, Snow T, Wang TT, Solis D, Vaughan L, Verghese M, Maecker H, Wittman R, Puri R, Kistler A, Yang S, Boyd SD, Pinsky BA, Chinthrajah S, Nadeau KC.

2022-07-0833 citations

10.1172/jci.insight.156713

Interventions

OTHERThere is no intervention

There is no intervention

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis). * Adults (18 years and older) and children without COVID-19 for controls (who test negative for COVID-19 but may have viral symptoms)

Exclusion criteria

* Patients with special risks attendant to venipuncture will be excluded.

Design outcomes

Primary

Measure	Time frame
Testing Immunity to SARS-CoV-2 over time	1 year

Secondary

Measure	Time frame
Testing the virus over time	1 year

Countries

United States

Outcome results

None listed